Chika Nitani

Dr. Chika Nitani

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2021 in Cancer Chemotherapy and Pharmacology
Verified
Journal Article
Closed access
PDF file
CNChika Nitani
Chika Nitani
JHJunichi Hara
Junichi Hara
HKHiroshi Kawamoto
Hiroshi Kawamoto
TTTomoaki Taguchi
Tomoaki Taguchi
TKToshimi Kimura
Toshimi Kimura
ASAkihiro Sato
Akihiro Sato

14 November 2024 in Current Oncology
Verified
Journal Article
Open access
PDF file
TATakuya Azechi
Takuya Azechi
YFYutaka Fukaya
Yutaka Fukaya
CNChika Nitani
Chika Nitani
JHJunichi Hara
Junichi Hara
HKHiroshi Kawamoto
Hiroshi Kawamoto
TOSHIMI KIMURATOSHIMI KIMURA
TOSHIMI KIMURA
Tamibarotene is a synthetic retinoid that inhibits tumor cell proliferation and promotes differentiation. We previously reported on the safety and tolerability of tamibarotene in patients with recurrent or refractory solid tumors. Therefore, in this study, we aimed to evaluate the pharmacokinetic properties of tamibarotene and construct a precise pharmacokinetic model. We also conducted a non-compartmental analysis and population pharmacokinetic (popPK) analysis based on the results of a phase I study. Targeted pediatric and young adult patients with recurrent or refractory solid tumors were administered tamibarotene at doses of 4, 6, 8, 10, and 12 g/m2/day. Serum tamibarotene concentrations were evaluated after administration, and a popPK model was constructed for tamibarotene using Phoenix NLME. During model construction, we considered the influence of various parameters (weight, height, body surface area, and age) as covariates. Notably, 22 participants were included in this study, and 109 samples were analyzed. A two-compartment model incorporating lag time was selected as the base model. In the final model, the body surface area was included as a covariate for apparent total body clearance, the central compartment volume of distribution, and the peripheral compartment volume of distribution. Visual prediction checks and bootstrap analysis confirmed the validity and predictive accuracy of the final model as satisfactory.

23 July 2026 in International Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
CNChika Nitani
Chika Nitani
JHJunichi Hara
Junichi Hara
HKHiroshi Kawamoto
Hiroshi Kawamoto
TTTomoaki Taguchi
Tomoaki Taguchi
YYYuki Yuza
Yuki Yuza
AHAkinobu Hamada
Akinobu Hamada

1 January 2026 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
MYMasaya Yamoto
Masaya Yamoto
HOHideto Ozawa
Hideto Ozawa
SIShuto Ikeda
Shuto Ikeda
CNChika Nitani
Chika Nitani
HFHiroyuki Fujisaki
Hiroyuki Fujisaki
MKMasafumi Kamiyama
Masafumi Kamiyama